How is Polpharma Biologics Innovating through the Integration of Advanced Cell Line Development Capabilities to Help Shape the Future of Healthcare?

Opublikowany: 01.12.2022

 

In Pharma’s Almanac  read more about integration of Bioceros’ capabilities into Polpharma Biologics. This change made Polpharma Biologics a truly integrated CDMO, offering the complete spectrum of services from discovery to commercial supply.

 

 

“Polpharma Biologics is now joining the ranks of leading CDMOs with a world-class offering to help partners take their product from concept to commercial supply”

 

 

written by: Polpharma Biologics

Współpracujmy, aby dostarczać wysokiej jakości leki biopodobne.

Skontaktuj się, aby uzyskać więcej informacji.